42768-60-5 Usage
Uses
Used in Pharmaceutical Industry:
BENZO(B)THIOPHENE-2-PROPIONIC ACID is used as a key building block for the synthesis of various pharmaceuticals due to its unique chemical structure that can be modified to create a range of therapeutic agents.
Used in Agrochemical Industry:
BENZO(B)THIOPHENE-2-PROPIONIC ACID also serves as a precursor in the development of agrochemicals, where its properties can be harnessed to create effective solutions for agricultural applications.
Used in Anti-Inflammatory Applications:
BENZO(B)THIOPHENE-2-PROPIONIC ACID is utilized as an anti-inflammatory agent, leveraging its chemical properties to potentially alleviate inflammation and associated conditions.
Used in Drug Synthesis:
As a precursor in the synthesis of new drug compounds, BENZO(B)THIOPHENE-2-PROPIONIC ACID plays a crucial role in medicinal chemistry, contributing to the discovery and development of novel therapeutics.
Check Digit Verification of cas no
The CAS Registry Mumber 42768-60-5 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 4,2,7,6 and 8 respectively; the second part has 2 digits, 6 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 42768-60:
(7*4)+(6*2)+(5*7)+(4*6)+(3*8)+(2*6)+(1*0)=135
135 % 10 = 5
So 42768-60-5 is a valid CAS Registry Number.
InChI:InChI=1/C7H5Cl2NO2/c1-12-7(11)6-4(8)2-10-3-5(6)9/h2-3H,1H3
42768-60-5Relevant academic research and scientific papers
Chatterjee, Amareshwar,Sen, Bhaskar,Chatterjee, Swapan K.
, p. 1707 - 1711 (1981)
Transformations of some 1-benzothiepin derivatives (1) into a 1-benzothiophen derivative (2a) through ring contraction are reported.Similar ring contraction of trans-1,2-dibromo-1,2,3,4-tetrahydronaphthothiepin (8) affords the thiophen derivative (9a).Treatment of the bromo-compounds (2a) and (9a) with base in the presence of catalysts provides in excelent yields the dienes (2d) and (9b) respectively.
CCK ANALOGS WITH APPETITE REGULATING ACTIVITY
-
, (2008/06/13)
The invention is directed to novel CCK analogs wherein Tryptophan and/or Phenylalamine are substituted with a radical which provides enhanced appetite suppressant activity to the peptide.
